Multiplex Assay Kit for Enolase 1 (ENO1) ,etc. by CBA (Cytometric Bead Array)

NNE; ENO1L1; MPB1; PPH; Alpha Enolase; Enolase 1; Phosphopyruvate hydratase; Plasminogen-binding protein; 2-phospho-D-glycerate hydro-lyase; C-myc promoter-binding

Specificity

This assay has high sensitivity and excellent specificity for detection of Enolase 1 (ENO1) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Enolase 1 (ENO1) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Enolase 1 (ENO1) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Enolase 1 (ENO1) ,etc. by CBA (Cytometric Bead Array) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 87-101 93
EDTA plasma(n=5) 96-105 101
heparin plasma(n=5) 79-104 89

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Enolase 1 (ENO1) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Enolase 1 (ENO1) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Enolase 1 (ENO1) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 86-93% 81-97% 89-97% 93-105%
EDTA plasma(n=5) 98-105% 80-99% 85-94% 79-93%
heparin plasma(n=5) 92-104% 96-105% 96-105% 84-92%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Analytical Chemistry Diagnostic detection of human lung cancer-associated antigen using a gold nanoparticle-based electrochemical immunosensor PubMed: 20557064
Translational Research Proteomic analysis of fine-needle aspiration in differential diagnosis of thyroid nodules Pubmed:27172385
Journal of Proteomics Putative salivary biomarkers useful to differentiate patients with fibromyalgia Pubmed:29654921
BioMed Research International The Diagnostic Accuracy of Combined Enolase/Cr, CA125, and CA19-9 in the Detection of Endometriosis Pubmed: 33062681
Cancer Cell International Bufalin Induced Mitochondrial Dysfunction Promotes Apoptosis of Glioma Cells by Regulating Annexin A2 and DRP1 Proteins
Cancer Cell Int Bufalin induces mitochondrial dysfunction and promotes apoptosis of glioma cells by regulating Annexin A2 and DRP1 protein expression 34376212
Clin Proteomics Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma Pubmed:35610567
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB449Hu03 Recombinant Enolase 1 (ENO1) Positive Control; Immunogen; SDS-PAGE; WB.
RPB449Hu02 Recombinant Enolase 1 (ENO1) Positive Control; Immunogen; SDS-PAGE; WB.
RPB449Hu01 Recombinant Enolase 1 (ENO1) Positive Control; Immunogen; SDS-PAGE; WB.
PAB449Hu02 Polyclonal Antibody to Enolase 1 (ENO1) WB,IHC
PAB449Hu03 Polyclonal Antibody to Enolase 1 (ENO1) WB,IHC,ICC/IF
PAB449Hu01 Polyclonal Antibody to Enolase 1 (ENO1) WB,IHC,ICC/IF
LAB449Hu71 Biotin-Linked Polyclonal Antibody to Enolase 1 (ENO1) WB
MAB449Hu21 Monoclonal Antibody to Enolase 1 (ENO1) WB
MAB449Hu27 Monoclonal Antibody to Enolase 1 (ENO1) WB
MAB449Hu28 Monoclonal Antibody to Enolase 1 (ENO1) WB,IHC
MAB449Hu29 Monoclonal Antibody to Enolase 1 (ENO1) WB,IHC
MAB449Hu22 Monoclonal Antibody to Enolase 1 (ENO1) WB; IHC
MAB449Hu23 Monoclonal Antibody to Enolase 1 (ENO1) WB
MAB449Hu24 Monoclonal Antibody to Enolase 1 (ENO1) WB
MAB449Hu25 Monoclonal Antibody to Enolase 1 (ENO1) WB
MAB449Hu26 Monoclonal Antibody to Enolase 1 (ENO1) WB; IHC
SEB449Hu ELISA Kit for Enolase 1 (ENO1) Enzyme-linked immunosorbent assay for Antigen Detection.
AEB449Hu ELISA Kit for Anti-Enolase 1 Antibody (Anti-ENO1) Enzyme-linked immunosorbent assay for Antibody Detection.
SCB449Hu CLIA Kit for Enolase 1 (ENO1) Chemiluminescent immunoassay for Antigen Detection.
LMB449Hu Multiplex Assay Kit for Enolase 1 (ENO1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CMB449Hu Multiplex Assay Kit for Enolase 1 (ENO1) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.